Ian Cooper

InvestorPlace Contributor

Ian Cooper has helped traders grow and protect their wealth since 1999.

Over the last 24 years, he’s taught thousands of investors how to trade news flow and herd mentality using a unique blend of technical and fundamental analysis. In fact, Cooper created the ADD News Flow Strategy, which allows us to trade the anticipation, dissemination, and the death of news flow by exploiting herd mentality.

Cooper was among the few analysts to spot the financial crisis of 2008, the top of subprime and Alt-A, the death of Lehman Brothers, Bear Stearns, and New Century Financial, and even the Dow’s collapse to 6,500, as well as its recovery. He even called for gold to rally well above $1.500 when it traded under $600.

At the moment, Cooper makes use of technical, fundamental and news analysis, to help individual investors grow their wealth. He’s a firm believer that hard work and thorough research will lead to investment success.

Recent Articles

3 Top Blue-Chip Stocks to Buy and Hold Now

By Ian Cooper, InvestorPlace Contributor Jan 10, 2020

Everyone wants to find big rewards without taking big risks. That's a tough order, but blue-chip stocks offer investors some great potential.

This Revival in NIO Stock Isn’t a Signal That It’s a Good Buy

By Ian Cooper, InvestorPlace Contributor Jan 10, 2020

While recent earnings and forecasts are certainty inspiring, the company keeps struggling. Nio stock is still worth avoiding.

Why Micron Is One of the Best Stocks to Own in 2020

By Ian Cooper, InvestorPlace Contributor Jan 9, 2020

With the 5G boom upon us, coupled with potential smartphone demand, MU is one of the top semiconductor stocks to own in 2020.

Canopy Growth Stock Looks Ready to Gain From Big Catalysts in 2020

By Ian Cooper, InvestorPlace Contributor Jan 6, 2020

Canopy Growth stock investors are excited about a new CEO at the helm and new Cannabis 2.0 products on the way. CGC stock looks primed for 2020.

3 Top Drug Stocks to Own In 2020

By Ian Cooper, InvestorPlace Contributor Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.